GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Santen Pharmaceutical Co 4536.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,894

+0.64%

Close of 6 Nov 2026, in JPY

Latest on Santen Pharmaceutical Co

Our reporting

Next results

5 Nov 2026

Due on 5 Nov 2026. Analysts expect earnings of 31.39 a share on revenue of ¥72.80bn.

Past results

Reported against what analysts expected

6 Aug 202612 May 20265 Feb 20266 Nov 20257 Aug 20256 Feb 2025
Earnings per share22.3847.8824.4024.4417.3225.33
Forecast21.2730.7929.2920.8923.9024.24
Revenue¥68.96bn¥80.86bn¥72.88bn¥69.14bn¥68.74bn¥76.37bn
Forecast¥70.38bn¥76.98bn¥75.68bn¥69.63bn¥72.34bn¥76.55bn

Key events

  1. 27 Mar 20155-for-1 share split
  2. 26 Mar 19971.1-for-1 share split
  3. 26 Mar 19961.1-for-1 share split
  4. 28 Mar 19951.1-for-1 share split
  5. 28 Mar 19941.1-for-1 share split
  6. 26 Mar 19931.1-for-1 share split

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.